Regulatory authorities face numerous challenges, including the rapid pace of scientific advancements and the complexity of new therapies. Balancing innovation with safety is a constant challenge, as is dealing with increasing volumes of data from clinical trials. Additionally, authorities must address disparities in access to treatments and ensure that regulatory processes are both rigorous and efficient.
